| CELC - Celcuity Inc (Healthcare: Diagnostics & Research) | Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10) |
|
|
|||||||||||||||||
|
|
|
| Company Profile | |
| Celcuity Inc is active in the healthcare domain. It is a cellular analysis company that is discovering new cancer sub-types and commercialising diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses the patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. | |
| Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. |